PMDA — authorised 20 September 2019
- Marketing authorisation holder: Novo Nordisk Pharma Ltd.
- Status: approved
PMDA authorised Novolog on 20 September 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 20 September 2019.
Novo Nordisk Pharma Ltd. holds the Japanese marketing authorisation.